Arcus Biosciences RCUS Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's accrued expenses?
- Arcus Biosciences (RCUS) reported accrued expenses of $19M in Q1 2026.
- How has Arcus Biosciences's accrued expenses changed year-over-year?
- Arcus Biosciences's accrued expenses increased by 11.8% year-over-year, from $17M to $19M.
- What is the long-term trend for Arcus Biosciences's accrued expenses?
- Over 5 years (2020 to 2025), Arcus Biosciences's accrued expenses has grown at a 56.1% compound annual growth rate (CAGR), from $3.57M to $33M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.